secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2024-12-17T23:59:59+00:00
Accession:  0001193125-24-280092
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics' SVP & Interim PAO Chihiro Saito resigns effective Dec 16, 2024
--------------------------------------------------------------------------------

- Chihiro Saito resigned as SVP, Accounting and Financial Operations and Interim Principal Accounting Officer.
- Resignation is to pursue another opportunity; not due to any disagreement with Tenaya.
- No replacement or timeline for successor announced in the filing.
- Departure leaves interim accounting leadership role vacant at the biotech firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312524280092/0001193125-24-280092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312524280092/d889423d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-280092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer